BCLSI
Bain Capital Life Sciences Investors’s NewAmsterdam Pharma NAMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194M | Hold |
10,719,110
| – | – | 24.29% | 1 |
|
|
2025
Q1 | $219M | Hold |
10,719,110
| – | – | 32.46% | 1 |
|
|
2024
Q4 | $275M | Buy |
10,719,110
+245,197
| +2% | +$6.3M | 32.41% | 1 |
|
|
2024
Q3 | $174M | Hold |
10,473,913
| – | – | 18.09% | 2 |
|
|
2024
Q2 | $201M | Hold |
10,473,913
| – | – | 22.09% | 2 |
|
|
2024
Q1 | $248M | Hold |
10,473,913
| – | – | 19.91% | 1 |
|
|
2023
Q4 | $117M | Hold |
10,473,913
| – | – | 11.21% | 2 |
|
|
2023
Q3 | $96.9M | Hold |
10,473,913
| – | – | 10.83% | 3 |
|
|
2023
Q2 | $125M | Buy |
10,473,913
+2,173,913
| +26% | +$25.8M | 12.83% | 2 |
|
|
2023
Q1 | $110M | Hold |
8,300,000
| – | – | 13.76% | 1 |
|
|
2022
Q4 | $90.5M | Buy |
+8,300,000
| New | +$90.5M | 10.11% | 3 |
|